Production (Stage)
Compugen Ltd.
CGEN
$1.65
$0.01070.65%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 469.60% | 380.24% | 346.12% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 469.60% | 380.24% | 346.12% | |
| Cost of Revenue | -- | 480.31% | 321.13% | 105.54% | |
| Gross Profit | -- | 468.00% | 389.07% | 382.07% | |
| SG&A Expenses | -- | -9.23% | -11.60% | -11.34% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 8.44% | 10.13% | 8.34% | |
| Operating Income | -- | 87.40% | 68.04% | 63.27% | |
| Income Before Tax | -- | 98.48% | 76.78% | 70.91% | |
| Income Tax Expenses | -- | 40,900.00% | 12,519.72% | 15,365.52% | |
| Earnings from Continuing Operations | -- | 71.52% | 49.94% | 44.34% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | 71.52% | 49.94% | 44.34% | |
| EBIT | -- | 87.40% | 68.04% | 63.27% | |
| EBITDA | -- | 88.57% | 68.97% | 64.15% | |
| EPS Basic | -- | 72.35% | 50.81% | 44.54% | |
| Normalized Basic EPS | -- | 230.59% | 172.35% | 172.35% | |
| EPS Diluted | -- | 72.40% | 50.89% | 44.64% | |
| Normalized Diluted EPS | -- | 230.59% | 172.35% | 172.35% | |
| Average Basic Shares Outstanding | -- | 2.51% | 2.03% | 1.25% | |
| Average Diluted Shares Outstanding | -- | 2.51% | 2.03% | 1.25% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |